Pivikto 200mg Tablet

By Pivikto

Rx

14 Tablet in a Strip

Composition icon

Composition

Alpelisib(200mg)

Manufacturer - Novartis India Ltd icon

Manufacturer - Novartis India Ltd

Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after icon

Expires on or after

July, 2025

About Pivikto 200mg Tablet

Pivikto 200mg Tablet is a medication used in the treatment of specific types of breast cancer. These include hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, and PIK3CAmutated breast cancer that has advanced or spread to other organs. This tablet is typically prescribed alongside hormonal anticancer therapies for maximum effectiveness.

It is essential to take Pivikto 200mg Tablet with food and at the same time each day to ensure consistent absorption for optimal results. Your doctor will determine the appropriate dosage and frequency based on your condition, which may be adjusted periodically. Adhering to your doctor's instructions is crucial as incorrect usage or overdose can lead to severe side effects. While it may take some time for the benefits of the medication to manifest, it is important not to discontinue treatment without consulting your doctor.

Common side effects of Pivikto 200mg Tablet may include fatigue, decreased appetite, rash, vomiting, and diarrhea. This medication can also lower the levels of certain blood cells, making you more prone to infections. Notify your doctor if you experience signs of infection such as fever, chills, weakness, bleeding, or bruising. Additionally, be cautious of dizziness, and avoid activities like driving that require alertness if you feel dizzy while taking this medication.

Before initiating treatment with Pivikto 200mg Tablet, inform your doctor about any existing heart disease, liver or kidney issues, or current use of medications for infections. Due to potential interactions, it is crucial to disclose all drugs you are taking to your healthcare provider. It is advised not to use this medication during pregnancy or while breastfeeding. Both males and females undergoing treatment with Pivikto 200mg Tablet should use reliable contraception to prevent pregnancy.


Benefits

Pivikto 200mg Tablet is an effective medication used in the treatment of breast cancer. It can be taken alone or in combination with other treatments like chemotherapy. This tablet helps to alleviate symptoms associated with breast cancer, such as breast lumps, bloody discharge from nipples, or changes in the shape or texture of the breast. The main advantage of Pivikto 200mg Tablet is its ability to kill cancer cells and inhibit their growth, ultimately preventing their multiplication. It is crucial to have a discussion with your doctor if you experience any side effects while taking this medication. Pivikto 200mg Tablet provides significant benefits in fighting breast cancer and improving the quality of life for patients undergoing treatment.


How to use the Pivikto 200mg Tablet

To properly use Pivikto 200mg Tablet, follow your doctor's instructions on dosage and duration. The tablet should be swallowed whole with a glass of water. It is important not to chew, crush, or break the tablet as it may alter its effectiveness. Take Pivikto 200mg Tablet with food to help avoid any potential stomach discomfort. Remember to strictly adhere to your doctor's recommendations to ensure the medication works as intended. If you have any questions or concerns about how to use this medication, consult your healthcare provider for guidance.


Uses of Pivikto 200mg Tablet

Uses of Pivikto 200mg Tablet for Breast Cancer Treatment

Pivikto 200mg Tablet is primarily used in the treatment of breast cancer. This medication is known for its effectiveness in managing and combating the progression of breast cancer. The active ingredient in Pivikto 200mg Tablet plays a crucial role in targeting cancer cells specific to breast tissue, thereby working to inhibit their growth and proliferation. By specifically focusing on breast cancer, this tablet aids in reducing the size of tumors and preventing the spread of cancerous cells in the body. Patients prescribed with Pivikto 200mg Tablet can benefit from its targeted approach in tackling breast cancer, offering them a potential lifeline in their battle against this disease.


What conditions Pivikto 200mg Tablet treats?

Pivikto 200mg Tablet is used to treat certain types of breast cancer, including hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated advanced breast cancer that has spread to other organs. It is typically prescribed alongside hormonal anticancer treatments. This medication targets breast cancer symptoms like lumps, nipple discharge, or changes in breast texture, working to halt cancer cell growth and multiplication. It may take time to see benefits, so consistent daily intake is crucial. Be vigilant for side effects like fatigue, decreased appetite, rash, vomiting, and diarrhea. Inform your doctor promptly if you notice signs of infection or experience dizziness.


Should you consult a doctor?

If you experience symptoms of infection like fever, chills, weakness, bleeding, bruising, or nose bleeding, it is advised to seek medical attention promptly. Additionally, if you notice persistent side effects such as diarrhea, rash, vomiting, fatigue, or dizziness, consulting your doctor is important. Inform your healthcare provider if you observe any changes in your blood cell counts, glucose levels, creatinine levels, or liver enzymes while taking Pivikto 200mg Tablet. It is crucial to seek medical advice if you have concerns about the side effects or if any new symptoms develop. Furthermore, individuals with pre-existing heart, liver, or kidney conditions should communicate with their doctor before starting the medication. If you are pregnant, breastfeeding, or planning a pregnancy, it is essential to discuss this with your healthcare team before initiating treatment with Pivikto 200mg Tablet. Remember that using effective contraception during treatment is vital to prevent pregnancy.


Side effects of Pivikto 200mg Tablet

When taking Pivikto 200mg Tablet, some individuals may experience certain side effects. These effects are typically mild and often diminish as your body gets used to the medication. However, if any of the following side effects persist or cause concern, it is important to consult with your healthcare provider.

Common side effects may include diarrhea, rash, increased glucose levels in the blood, nausea, vomiting, fatigue, and increased creatinine levels in the blood. Additionally, some individuals may experience lymphocytopenia, increased gamma-glutamyltransferase, increased alanine aminotransferase, decreased hemoglobin levels, increased lipase in the blood, decreased appetite, and stomatitis (inflammation of the mouth).

Other potential side effects of Pivikto 200mg Tablet may include weight loss, hypoglycemia (low blood glucose levels), decreased calcium levels in the blood, prolonged activated partial thromboplastin time (aPTT), and hair loss. It is essential to keep track of any side effects experienced and discuss them with your doctor to ensure your well-being and proper management of any potential concerns.


Safety advice

scroll

liver

Pivikto 200mg Tablet is considered safe for use in individuals with liver disease. It is not necessary to adjust the dose of Pivikto 200mg Tablet specifically for liver-related concerns. This medication can be used as directed without any modifications in patients with liver issues.

scroll

kidney

Limited information is available regarding the use of Pivikto 200mg Tablet in patients with kidney disease. Please consult your doctor for guidance.

scroll

alcohol

Consult your doctor when consuming alcohol with Pivikto 200mg Tablet.

scroll

driving

It is not clear if Pivikto 200mg Tablet affects driving. Avoid driving if you have symptoms impacting focus or reaction time.

scroll

pregnancy

Pivikto 200mg Tablet is not recommended during pregnancy, as animal studies suggest potential harm to the developing baby. Consult your doctor for a careful evaluation of benefits versus risks before using this medication.

scroll

breastfeeding

Pivikto 200mg Tablet may not be safe during breastfeeding as it may pass into breastmilk and harm the baby. Limited human data suggests caution.


Consumption warning before consuming Pivikto 200mg Tablet

Before consuming Pivikto 200mg Tablet, remember the following warnings: Always take the tablet with food at the same time daily for optimal benefits as directed by your doctor. The dosage and frequency will be determined by your doctor based on your condition. Taking more than prescribed or incorrectly can lead to severe side effects. It may take time to notice improvements, so do not stop without your doctor's approval. Possible side effects include fatigue, decreased appetite, rash, vomiting, and diarrhea. This medicine can lower blood cell count, making you prone to infections, so notify your doctor if you experience symptoms like fever or bleeding. Be cautious of dizziness and refrain from driving if affected. Inform your doctor of any heart, liver, or kidney issues, ongoing medications, pregnancy, or breastfeeding status. Use effective contraception during treatment to prevent pregnancy.


Related lab tests

For individuals taking Pivikto 200mg Tablet, it is important to monitor certain lab tests related to Breast Cancer. These tests include CA 15.3, ER (Estrogen Receptor), and PR (Progesterone Receptor) tests. CA 15.3 is a tumor marker commonly used to monitor the progression of certain types of breast cancer. The ER and PR tests are done to determine if the cancer cells have receptors for the hormones estrogen and progesterone, which can influence treatment decisions. Monitoring these tests regularly can provide valuable information to healthcare providers regarding the effectiveness of treatment and the overall status of the breast cancer. It is recommended to discuss with your healthcare provider about the frequency and importance of these lab tests while taking Pivikto 200mg Tablet.


Additional Information

Habit FormingNo
Chemical ClassProline and derivatives
Therapeutic Class-
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

34000

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 11-Feb-2025